Literature DB >> 25999212

Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers.

Erikka Loftfield1, Meredith S Shiels2, Barry I Graubard2, Hormuzd A Katki2, Anil K Chaturvedi2, Britton Trabert2, Ligia A Pinto3, Troy J Kemp3, Fatma M Shebl4, Susan T Mayne4, Nicolas Wentzensen2, Mark P Purdue5, Allan Hildesheim2, Rashmi Sinha2, Neal D Freedman2.   

Abstract

BACKGROUND: Coffee drinking has been inversely associated with mortality as well as cancers of the endometrium, colon, skin, prostate, and liver. Improved insulin sensitivity and reduced inflammation are among the hypothesized mechanisms by which coffee drinking may affect cancer risk; however, associations between coffee drinking and systemic levels of immune and inflammatory markers have not been well characterized.
METHODS: We used Luminex bead-based assays to measure serum levels of 77 immune and inflammatory markers in 1,728 older non-Hispanic Whites. Usual coffee intake was self-reported using a food frequency questionnaire. We used weighted multivariable logistic regression models to examine associations between coffee and dichotomized marker levels. We conducted statistical trend tests by modeling the median value of each coffee category and applied a 20% false discovery rate criterion to P values.
RESULTS: Ten of the 77 markers were nominally associated (P trend < 0.05) with coffee drinking. Five markers withstood correction for multiple comparisons and included aspects of the host response namely chemotaxis of monocytes/macrophages (IFNγ, CX3CL1/fractalkine, CCL4/MIP-1β), proinflammatory cytokines (sTNFRII), and regulators of cell growth (FGF-2). Heavy coffee drinkers had lower circulating levels of IFNγ [odds ratios (OR), 0.35; 95% confidence intervals (CI), 0.16-0.75], CX3CL1/fractalkine (OR, 0.25; 95% CI, 0.10-0.64), CCL4/MIP-1β (OR, 0.48; 95% CI, 0.24-0.99), FGF-2 (OR, 0.62; 95% CI, 0.28-1.38), and sTNFRII (OR, 0.34; 95% CI, 0.15-0.79) than non-coffee drinkers.
CONCLUSIONS: Lower circulating levels of inflammatory markers among coffee drinkers may partially mediate previously observed associations of coffee with cancer and other chronic diseases. IMPACT: Validation studies, ideally controlled feeding trials, are needed to confirm these associations. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25999212      PMCID: PMC4490956          DOI: 10.1158/1055-9965.EPI-15-0038-T

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  52 in total

Review 1.  Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies.

Authors:  Jennifer Stella Bonita; Michael Mandarano; Donna Shuta; Joe Vinson
Journal:  Pharmacol Res       Date:  2007-01-26       Impact factor: 7.658

Review 2.  Effects of coffee on type 2 diabetes mellitus.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Shuqing Chen
Journal:  Nutrition       Date:  2013-12-05       Impact factor: 4.008

3.  Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease.

Authors:  Michael Shechter; Guy Shalmon; Mickey Scheinowitz; Nira Koren-Morag; Micha S Feinberg; Dror Harats; Ben Ami Sela; Yehonatan Sharabi; Pierre Chouraqui
Journal:  Am J Cardiol       Date:  2011-02-23       Impact factor: 2.778

4.  Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies.

Authors:  Carlotta Galeone; Federica Turati; Carlo La Vecchia; Alessandra Tavani
Journal:  Cancer Causes Control       Date:  2010-08-01       Impact factor: 2.506

5.  Caffeine intake, smoking, and risk of Parkinson disease in men and women.

Authors:  Rui Liu; Xuguang Guo; Yikyung Park; Xuemei Huang; Rashmi Sinha; Neal D Freedman; Albert R Hollenbeck; Aaron Blair; Honglei Chen
Journal:  Am J Epidemiol       Date:  2012-04-13       Impact factor: 4.897

Review 6.  Methylxanthines and inflammatory cells.

Authors:  György Haskó; Bruce Cronstein
Journal:  Handb Exp Pharmacol       Date:  2011

7.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

8.  Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.

Authors:  Simone Jacobs; Janine Kröger; Anna Floegel; Heiner Boeing; Dagmar Drogan; Tobias Pischon; Andreas Fritsche; Cornelia Prehn; Jerzy Adamski; Berend Isermann; Cornelia Weikert; Matthias B Schulze
Journal:  Am J Clin Nutr       Date:  2014-07-23       Impact factor: 7.045

9.  Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-kappaB.

Authors:  Pankaj K Bhavsar; Maria B Sukkar; Nadia Khorasani; Kang-Yun Lee; Kian Fan Chung
Journal:  FASEB J       Date:  2008-01-29       Impact factor: 5.191

10.  Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption.

Authors:  S Salvini; D J Hunter; L Sampson; M J Stampfer; G A Colditz; B Rosner; W C Willett
Journal:  Int J Epidemiol       Date:  1989-12       Impact factor: 7.196

View more
  28 in total

1.  Association of Coffee and Tea Intake with the Oral Microbiome: Results from a Large Cross-Sectional Study.

Authors:  Brandilyn A Peters; Marjorie L McCullough; Mark P Purdue; Neal D Freedman; Caroline Y Um; Susan M Gapstur; Richard B Hayes; Jiyoung Ahn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-04-27       Impact factor: 4.254

2.  Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis.

Authors:  Giuseppe Grosso; Agnieszka Micek; Justyna Godos; Salvatore Sciacca; Andrzej Pajak; Miguel A Martínez-González; Edward L Giovannucci; Fabio Galvano
Journal:  Eur J Epidemiol       Date:  2016-10-03       Impact factor: 8.082

3.  Circulating inflammation markers and colorectal adenoma risk.

Authors:  Wen-Yi Huang; Sonja I Berndt; Meredith S Shiels; Hormuzd A Katki; Anil K Chaturvedi; Nicolas Wentzensen; Britton Trabert; Troy J Kemp; Ligia A Pinto; Allan Hildesheim; Nathaniel Rothman; Mark P Purdue
Journal:  Carcinogenesis       Date:  2019-07-06       Impact factor: 4.944

4.  Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank.

Authors:  Erikka Loftfield; Marilyn C Cornelis; Neil Caporaso; Kai Yu; Rashmi Sinha; Neal Freedman
Journal:  JAMA Intern Med       Date:  2018-08-01       Impact factor: 21.873

5.  Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions.

Authors:  Jill Koshiol; Yu-Tang Gao; Amanda Corbel; Troy J Kemp; Ming-Chang Shen; Allan Hildesheim; Ann W Hsing; Asif Rashid; Bingsheng Wang; Ruth M Pfeiffer; Ligia A Pinto
Journal:  Cancer Epidemiol       Date:  2018-03-16       Impact factor: 2.984

Review 6.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

Review 7.  Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.

Authors:  M Noureddin; Q M Anstee; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2016-04-08       Impact factor: 8.171

8.  Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations.

Authors:  Song-Yi Park; Neal D Freedman; Christopher A Haiman; Loïc Le Marchand; Lynne R Wilkens; Veronica Wendy Setiawan
Journal:  Ann Intern Med       Date:  2017-07-11       Impact factor: 25.391

9.  Caffeinated Coffee Consumption and Health Outcomes in the US Population: A Dose-Response Meta-Analysis and Estimation of Disease Cases and Deaths Avoided.

Authors:  Matteo Di Maso; Paolo Boffetta; Eva Negri; Carlo La Vecchia; Francesca Bravi
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

10.  Targeting Melanoma-Initiating Cells by Caffeine: In Silico and In Vitro Approaches.

Authors:  Claudio Tabolacci; Martina Cordella; Stefania Rossi; Marialaura Bonaccio; Adriana Eramo; Carlo Mischiati; Simone Beninati; Licia Iacoviello; Antonio Facchiano; Francesco Facchiano
Journal:  Molecules       Date:  2021-06-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.